Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in autoimmune liver diseases

M P Manns1

  • 1Department of Gastroenterology and Hepatology, Hannover Medical School, Germany.

Journal of Gastroenterology and Hepatology
|January 4, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virological and clinical characteristics of delta hepatitis in Central Europe.

Journal of viral hepatitis·2009
Same author

Hepatitis C virus-specific T cell responses against conserved regions in recovered patients.

Vaccine·2009
Same author

Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.

Zeitschrift fur Gastroenterologie·2009
Same author

[Liver transplantation: indications and results].

Der Internist·2009
Same author

[Transplantation medicine 2009].

Der Internist·2009
Same author

Transient autoimmune hepatitis induced by a thymoma.

The American journal of gastroenterology·2009

This review covers autoimmune liver diseases, including autoimmune hepatitis, primary biliary cirrhosis, and drug-induced conditions. It highlights progress in understanding autoimmune hepatitis and related immune-mediated liver disorders.

Area of Science:

  • Hepatology
  • Immunology
  • Gastroenterology

Background:

  • Autoimmune liver diseases encompass a spectrum of conditions.
  • These include primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis.
  • Autoimmunity can also manifest in viral hepatitis and drug-induced liver injury.

Purpose of the Study:

  • To review recent advancements in the understanding of autoimmune hepatitis.
  • To discuss autoimmune polyendocrine syndrome type 1 (APS-1) and its relation to liver disease.
  • To explore autoimmunity in viral hepatitis and immune-mediated drug-induced liver disease.

Main Methods:

  • Literature review of recent progress in autoimmune liver diseases.
  • Focus on autoimmune hepatitis, APS-1, viral hepatitis autoimmunity, and drug-induced liver disease.

Related Experiment Videos

  • Synthesis of current knowledge and research findings.

    • Main Results:

    • Autoimmune hepatitis is a significant autoimmune liver disease.
    • Overlap syndromes and specific conditions like APS-1 present complex autoimmune profiles.
    • Autoantibodies are relevant in chronic viral hepatitis (C and D) and some drug-induced liver diseases.

    Conclusions:

    • Continued research is vital for understanding and managing autoimmune liver diseases.
    • Distinguishing autoimmune hepatitis from other liver conditions is crucial for effective treatment.
    • Immune-mediated pathways play a role in various chronic liver diseases.